Julien Forestier - Publications

PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2025

Serum and urinary 5-hydroxyindolacetic acid, serotonin, chromogranin A, and NT-proBNP for the detection of carcinoid heart disease.

Journal: European journal of endocrinology

Published: July 08, 2024

Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 11, 2023

Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence.

Journal: Endocrine connections

Published: April 11, 2022

FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 06, 2022

Transcatheter Pulmonary Valve Implantation in Carcinoid Heart Disease.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: October 28, 2021

Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study.

Journal: Cancers

Published: March 01, 2021

Role of FOLFIRINOX and chemoradiotherapy in locally advanced and borderline resectable pancreatic adenocarcinoma: update of the AGEO cohort.

Journal: British journal of cancer

Published: December 18, 2020

Value of a patient-reported-outcome measure of carcinoid syndrome symptoms.

Journal: European journal of endocrinology

Published: October 02, 2020

Unifocal versus Multiple Ileal Neuroendocrine Tumors Location: An Embryological Origin.

Journal: Neuroendocrinology

Published: June 08, 2020

Metformin and everolimus in neuroendocrine tumours: A synergic effect?

Journal: Clinics and research in hepatology and gastroenterology

Published: November 25, 2019

Management and Prognosis of Localized Duodenal Neuroendocrine Neoplasms.

Journal: Neuroendocrinology

Published: November 19, 2019